Biogen’s controversial Alzheimer’s med Aduhelm turned away by VA on efficacy and safety worries
August 18, 2021
Biogen's controversial Alzheimer's med Aduhelm turned away by VA on efficacy and safety worries
fkansteiner
Wed, 08/11/2021 – 11:35
Read the source article at Pharma News
2021-08-11 16:30:52